Abstract
Young children are obligate nose breathers. When these patients develop severe congestion, they can present to the emergency department (ED) with difficulty feeding, tachypnea, retractions, and respiratory distress, despite nasal saline and suction at home. Intranasal oxymetazoline has been used in the adult population to counter congestion with a minimal side effect profile. It can offer an alternative management for parents and physicians. This is a preliminary safety study of using oxymetazoline in the pediatric population with the hypothesis that medication administration will not have a significant side effect on heart rate, blood pressure, or respiratory rate, and can be a safe treatment option for children 1 month to 12 months old.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
